171 related articles for article (PubMed ID: 24930498)
1. The effect of age on the systemic inflammatory response in patients with community-acquired pneumonia.
van Vught LA; Endeman H; Meijvis SC; Zwinderman AH; Scicluna BP; Biesma DH; van der Poll T
Clin Microbiol Infect; 2014 Nov; 20(11):1183-8. PubMed ID: 24930498
[TBL] [Abstract][Full Text] [Related]
2. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
[TBL] [Abstract][Full Text] [Related]
3. Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?
Kelly E; MacRedmond RE; Cullen G; Greene CM; McElvaney NG; O'Neill SJ
Respirology; 2009 Mar; 14(2):210-6. PubMed ID: 19272082
[TBL] [Abstract][Full Text] [Related]
4. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
Hedlund J
Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866
[TBL] [Abstract][Full Text] [Related]
5. Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia.
Igonin AA; Armstrong VW; Shipkova M; Lazareva NB; Kukes VG; Oellerich M
Clin Biochem; 2004 Mar; 37(3):204-9. PubMed ID: 14972642
[TBL] [Abstract][Full Text] [Related]
6. Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia.
Dwyer R; Hedlund J; Darenberg J; Henriques-Normark B; Naucler P; Runesdotter S; Kalin M
Scand J Infect Dis; 2011 Jul; 43(6-7):448-55. PubMed ID: 21370939
[TBL] [Abstract][Full Text] [Related]
7. Lower incidence of acute respiratory distress syndrome in community-acquired pneumonia patients aged 85 years or older.
Toba A; Yamazaki M; Mochizuki H; Noguchi T; Tsuda Y; Kawate E; Suzuki Y; Takahashi H
Respirology; 2010 Feb; 15(2):319-25. PubMed ID: 20070586
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response.
Tejera A; Santolaria F; Diez ML; Alemán-Valls MR; González-Reimers E; Martínez-Riera A; Milena-Abril A
Cytokine; 2007 Jun; 38(3):117-23. PubMed ID: 17659879
[TBL] [Abstract][Full Text] [Related]
9. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia.
Lee YL; Chen W; Chen LY; Chen CH; Lin YC; Liang SJ; Shih CM
J Crit Care; 2010 Mar; 25(1):176.e7-13. PubMed ID: 19592208
[TBL] [Abstract][Full Text] [Related]
10. IL-6 and TNF-α serum levels are associated with early death in community-acquired pneumonia patients.
Bacci MR; Leme RC; Zing NP; Murad N; Adami F; Hinnig PF; Feder D; Chagas AC; Fonseca FL
Braz J Med Biol Res; 2015 May; 48(5):427-32. PubMed ID: 25714883
[TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study.
Ferrer M; Torres A; Martínez R; Ramírez P; Polverino E; Montull B; Sialer S; Niederman MS; Agusti A; Menéndez R
Respirology; 2014 Aug; 19(6):929-35. PubMed ID: 24909304
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
Thiem U; Niklaus D; Sehlhoff B; Stückle C; Heppner HJ; Endres HG; Pientka L
Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.
Yang Y; Xu F; Shi LY; Diao R; Cheng YS; Chen XY; Jing JY; Wang XD; Shen HH
Chin Med J (Engl); 2012 Feb; 125(4):639-45. PubMed ID: 22490488
[TBL] [Abstract][Full Text] [Related]
14. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.
Antunes G; Evans SA; Lordan JL; Frew AJ
Eur Respir J; 2002 Oct; 20(4):990-5. PubMed ID: 12412694
[TBL] [Abstract][Full Text] [Related]
15. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
Ioachimescu OC; Ioachimescu AG; Iannini PB
Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
[TBL] [Abstract][Full Text] [Related]
16. Krueppel-Like Factor 4 Expression in Phagocytes Regulates Early Inflammatory Response and Disease Severity in Pneumococcal Pneumonia.
Herta T; Bhattacharyya A; Rosolowski M; Conrad C; Gurtner C; Gruber AD; Ahnert P; Gutbier B; Frey D; Suttorp N; Hippenstiel S; Zahlten J
Front Immunol; 2021; 12():726135. PubMed ID: 34589087
[TBL] [Abstract][Full Text] [Related]
17. The impact of time on the systemic inflammatory response in pneumococcal pneumonia.
Calbo E; Alsina M; Rodríguez-Carballeira M; Lite J; Garau J
Eur Respir J; 2010 Mar; 35(3):614-8. PubMed ID: 19608588
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia.
Remmelts HH; Meijvis SC; Heijligenberg R; Rijkers GT; Oosterheert JJ; Bos WJ; Endeman H; Grutters JC; Hoepelman AI; Biesma DH
J Infect; 2012 Jul; 65(1):25-31. PubMed ID: 22410382
[TBL] [Abstract][Full Text] [Related]
19. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
[TBL] [Abstract][Full Text] [Related]
20. [C-reactive protein, leukocyte count and ESR in the assessment of severity of community-acquired pneumonia].
Bircan A; Kaya O; Gökirmak M; Oztürk O; Sahin U; Akkaya A
Tuberk Toraks; 2006; 54(1):22-9. PubMed ID: 16615014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
